Dr. Agarwal's Eye Hospital Limited (BOM:526783)

Market Cap	25.66B +19.5%
Revenue (ttm)	4.97B +20.0%
Net Income	762.20M +31.9%
EPS	158.76 +29.1%
Shares Out	4.83M
PE Ratio	33.45
Forward PE	n/a
Dividend	7.00 (0.13%)
Ex-Dividend Date	Sep 2, 2026

Volume	190
Open	5,262.50
Previous Close	5,315.75
Day's Range	5,235.30 - 5,356.95
52-Week Range	4,412.05 - 6,392.00
Beta	-0.52
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2026

About BOM:526783

Dr. Agarwal's Eye Hospital Limited engages in the provision of eye care and related services in India, Ghana, Uganda, Kenya, Madagascar, Tanzania, Rwanda, Zambia, Mozambique, and Mauritius. The company, through its hospitals, offers services in the areas of cataract, glaucoma, laser correction, cornea and refractive, retina, squint, corneal ulcer, fungal keratitis, diabetic retinopathy, retinal detachment, nystagmus, ptosis, conjunctivitis, retinopathy prematurity, macular hole and edema, cornea transplantation, behcets, computer vision syndrom...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1957
• Employees: 1,356
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 526783

Financial Performance

In fiscal year 2026, BOM:526783's revenue was 4.71 billion, an increase of 18.56% compared to the previous year's 3.97 billion. Earnings were 701.00 million, an increase of 28.27%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 11, 2026

Data Sources Report a data error